Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CEP95 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101927057 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR173 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929694 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RPL32P3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF121 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAMM41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLX1B-SULT1A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HYI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL4A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENOSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NASP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS15A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF366 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFT27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on